MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
about
The Role of miRNAs in the Regulation of Pancreatic Cancer Stem CellsTargeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacyHarnessing the apoptotic programs in cancer stem-like cellsTargeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressivenessAntioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem CellsTargeting CSC-related miRNAs for cancer therapy by natural agentsNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancersLow adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1.Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.miR-589-5p inhibits MAP3K8 and suppresses CD90(+) cancer stem cells in hepatocellular carcinoma.Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis.MicroRNAs in endometrial cancer.Molecular research in penile cancer-lessons learned from the past and bright horizons of the future?Emerging role of microRNAs in cancer and cancer stem cells.The role of miRNAs in cancer: from pathogenesis to therapeutic implications.Clinical Aspect of MicroRNA in Lung Cancer.Metabolism in embryonic and cancer stemness.The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells.Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.microRNA regulation of human pancreatic cancer stem cells.MiR-155 Promotes Uveal Melanoma Cell Proliferation and Invasion by Regulating NDFIP1 Expression.
P2860
Q26752473-34D29997-D36B-4E6C-9D5F-32143580383FQ26784365-ACAE3C6F-A61E-48DE-85AD-9A1F368E1D9DQ26801037-427996F1-64C7-4285-9CD4-9CA459F5E0FEQ26822776-8B274EA4-8039-4CC8-A49A-DD33ED1D1D2BQ26853528-ABCA4A4D-1316-484E-914D-202E17FB8471Q27003230-A44CB8F5-0DEF-4E0A-8A1C-55DE415D5B87Q28078448-4723DA5B-2BF1-41C9-BB69-3C83CE6824CBQ34357952-78B102EE-7A0B-4F05-B079-93ED5F0CDA8DQ35890322-2CB1FAC4-F558-44BA-A58B-17D32402F3EFQ36183477-1A3F578A-4780-445E-BE0F-5D0A521ADC77Q36185083-887290A8-FF5B-4EC7-9146-6D043B8F38FCQ37070323-6977D79E-2FCA-427B-9955-E8234FB563DAQ37410466-8DCD7494-F30F-495E-95DA-9DD035CF21D7Q37662194-F89AFC7F-2E8A-459D-BE51-F63B03FC0384Q38079122-10DD9A60-8B9F-4B47-B3DB-9D69E1931DF7Q38146645-E5C845DD-08CA-441C-8DA2-AC70BE46AD41Q38156124-6B26EA49-7725-486A-B022-EC13F3FD0622Q38221290-87289068-2AC1-4AB9-9153-F263905E20A8Q38252575-39C4F29B-6C1B-4AA8-9525-7FDD4739D6C1Q38322832-E897EDC7-6006-4FFF-9A4E-E681BC39EC9BQ38826011-FAB3DB16-7B85-4A20-8C9E-9ABD27CE7EFAQ38958559-AFE4277E-8223-4DA8-B0AE-5A6AD3B6E36AQ39143971-65AE4250-6DA4-402C-83EB-F735F3B579FEQ49746337-11143AC7-2534-4B3B-9B90-03C02F337FDB
P2860
MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
@en
type
label
MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
@en
prefLabel
MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
@en
P1433
P1476
MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
@en
P2093
M E Lleonart
P304
P356
10.1016/J.CANLET.2012.04.020
P407
P577
2012-04-30T00:00:00Z